Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models

INTRODUCTION: Combination therapy for acute lymphoblastic leukemia (ALL) is highly effective but results in significant toxicity including osteonecrosis. Asparaginase is known to potentiate both the antileukemic and osteonecrosis-inducing effects of dexamethasone. The schedule of dexamethasone alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Karol, Seth E., Janke, Laura J., Panetta, John C., Ramsey, Laura B., Cai, Xiangjun, Payton, Monique A., Jenkins, David A., Evans, William E., Relling, Mary V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502315/
https://www.ncbi.nlm.nih.gov/pubmed/31059548
http://dx.doi.org/10.1371/journal.pone.0216328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502315/
https://www.ncbi.nlm.nih.gov/pubmed/31059548
http://dx.doi.org/10.1371/journal.pone.0216328

Ejemplares similares